Positive p53 Expression Is Associated with Primary Endocrine Therapy Resistance in Locally Advanced Stage Luminal B HER2-Negative Breast Cancer Patients: A Cross-Sectional Study in Indonesia

Luminal B HER2-negative breast cancer (BC) is the most common type in Indonesian BC patients, and frequently manifests with locally advanced staging. Recurrence often occurs within two years of the endocrine therapy course (primary endocrine therapy (ET) resistance). p53 mutation often exists in lum...

Full description

Bibliographic Details
Main Authors: Freda Halim, Yohana Azhar, Suwarman Suwarman, Eka Julianta Wahjoepramono, Bethy Hernowo
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/11/1838